668
Participants
Start Date
December 3, 2020
Primary Completion Date
July 13, 2022
Study Completion Date
July 13, 2022
BCG-Denmark
Participants randomized to receive BCG will receive one 0.1 ml dose of Mycobacterium bovis BCG live attenuated BCG-Denmark vaccine (AJ Vaccines, Copenhagen, Denmark) by intradermal injection in the left deltoid region.
Saline
Participants randomized to the control group will receive one 0.1 ml dose sterile 0.9 % NaCl by intradermal injection in the right deltoid region.
Bandim Health Project, Bissau
Manhiça Health Research Centre, Manhiça
Institute of Hygiene and Tropical Medicine, NOVA University, Lisbon, Portugal
UNKNOWN
University of Cape Verde, Praia, Cape Verde
UNKNOWN
National Institute of Public Health of Cape Verde, Praia, Cape Verde
UNKNOWN
Centro de Investigacao em Saude de Manhica
OTHER
European and Developing Countries Clinical Trials Partnership (EDCTP)
OTHER_GOV
Bandim Health Project, Bissau, Guinea-Bissau
UNKNOWN
University of Southern Denmark
OTHER